Results 141 to 150 of about 31,396 (267)
What Is Your Diagnosis? Multiple Subcutaneous Lumps in a Horse
Veterinary Clinical Pathology, EarlyView.
Federica Meistro +4 more
wiley +1 more source
ABSTRACT Cutaneous crystal‐storing histiocytosis (CSH) is an extremely rare histopathologic finding of histiocytes accumulating crystals of immunoglobulin or paraproteins, often associated with lymphoplasmacytic malignancies. It commonly presents in a wide age range of both female and male adults with a history of a lymphoproliferative disorder ...
Ashton Arlen +3 more
wiley +1 more source
Circulating Histiocytes and Hemophagocytosis in Peripheral Blood
Hakim Jaziri +3 more
doaj +1 more source
What Is Your Diagnosis? Blood Smear From a Mixed‐Breed Dog
Veterinary Clinical Pathology, EarlyView.
Laura S. Peres +5 more
wiley +1 more source
Ossifying spindled and epithelioid tumour (OSET) can show unusual morphologic features, including minimal or absent peripheral ossification, eosinophil‐rich stroma, increased mitotic activity (≥5 mitotic figures per 10 high‐power fields), and necrosis.
Rayan M Sibira +9 more
wiley +1 more source
Extranodal natural killer/T‐cell lymphoma: From fatal to curable
Abstract Extranodal natural killer (NK)/T‐cell lymphoma (ENKTCL) is one of the most aggressive non‐Hodgkin lymphomas characterized by NK‐cell or T‐cell origins, a geographic prevalence in Asian and South American populations, and Epstein–Barr virus (EBV) infection.
Jie Xiong +12 more
wiley +1 more source
아급성 괴사성 림프절염에서 Myeloperoxidase 양성 조직구의 CD11c과 CD163 면역염색 발현
Dept. of Medicine/석사Immunophenotype analysis of lesional histiocytes in subacute necrotizing lymphadenitis (SNL) has revealed several unexpected findings.
장선정
core
Cutaneous Rosai-Dorfman-Destombes disease: the diagnostic value of the yellow island sign. [PDF]
El Maati M +4 more
europepmc +1 more source
A Rare Soft Tissue Presentation of Mixed Histiocytosis with Multiple Disseminated Subcutaneous Masses. [PDF]
Miyagawa F +4 more
europepmc +1 more source
Rosai-Dorfman disease with <i>MAP2K1</i> mutation: therapeutic response to MEK inhibition after failure of conventional therapy. [PDF]
Barbosa Carvalho do Carmo C +5 more
europepmc +1 more source

